These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26818624)

  • 1. Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
    Li RR; Sheng XY; Ma LY; Yao HX; Cai LX; Chen CY; Zhu SN; Zhou Y; Wu Y; Cui YM
    Ther Drug Monit; 2016 Jun; 38(3):365-70. PubMed ID: 26818624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
    Miles MV; Tang PH; Ryan MA; Grim SA; Fakhoury TA; Strawsburg RH; DeGrauw TJ; Baumann RJ
    Ther Drug Monit; 2004 Jun; 26(3):300-4. PubMed ID: 15167632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
    Peng J; Zhang HN; Liu ZS; Xu H; Wang Y
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):684-92. PubMed ID: 24887335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YA; Zhou BT
    J Pharm Pharm Sci; 2015; 18(3):256-65. PubMed ID: 26517132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms.
    Yang X; Yan Y; Fang S; Zeng S; Ma H; Qian L; Chen X; Wei J; Gong Z; Xu Z
    Medicine (Baltimore); 2019 Mar; 98(12):e14908. PubMed ID: 30896644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma level monitoring of oxcarbazepine in epileptic patients.
    González-Esquivel DF; Ortega-Gavilán M; Alcántara-López G; Jung-Cook H
    Arch Med Res; 2000; 31(2):202-5. PubMed ID: 10880728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
    Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
    Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
    J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
    Mazzucchelli I; Onat FY; Ozkara C; Atakli D; Specchio LM; Neve AL; Gatti G; Perucca E
    Epilepsia; 2006 Mar; 47(3):504-9. PubMed ID: 16529613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis.
    Lin WW; Wang CL; Jiao Z; Yu XL; Zhang J; Zhang WB; Lin RF; Lin S; Lin XH
    Ther Drug Monit; 2019 Oct; 41(5):665-673. PubMed ID: 31033858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.
    Yu Y; Zhang Q; Xu W; Lv C; Hao G
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):345-51. PubMed ID: 25700977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.
    Wang Y; Zhang HN; Niu CH; Gao P; Chen YJ; Peng J; Liu MC; Xu H
    Acta Pharmacol Sin; 2014 Oct; 35(10):1342-50. PubMed ID: 25220641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
    Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
    Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic variability of oxcarbazepine in epileptic patients].
    Viola MS; Bercellini MA; Saidón P; Rubio MC
    Medicina (B Aires); 2000; 60(6):914-8. PubMed ID: 11436701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of oxcarbazepine.
    May TW; Korn-Merker E; Rambeck B
    Clin Pharmacokinet; 2003; 42(12):1023-42. PubMed ID: 12959634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of unbound plasma concentration of oxcarbazepine and the 10-hydroxycarbazepine enantiomers by liquid chromatography with tandem mass spectrometry in healthy volunteers.
    Antunes NJ; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Marques MP; Lanchote VL
    J Pharm Biomed Anal; 2018 Feb; 149():442-447. PubMed ID: 29169112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.
    Antunes Nde J; Wichert-Ana L; Coelho EB; Della Pasqua O; Alexandre Junior V; Takayanagui OM; Tozatto E; Marques MP; Lanchote VL
    Eur J Clin Pharmacol; 2016 Feb; 72(2):195-201. PubMed ID: 26514967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.